Cantor Fitzgerald Cuts Earnings Estimates for Teladoc Health

Teladoc Health, Inc. (NYSE:TDOC) – Stock analysts at Cantor Fitzgerald reduced their FY2025 EPS estimates for Teladoc Health in a research report issued on Thursday, May 1st. Cantor Fitzgerald analyst S. James now anticipates that the health services provider will post earnings of ($1.07) per share for the year, down from their prior estimate of ($0.78). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.16) per share.

A number of other equities research analysts have also recently weighed in on TDOC. Evercore ISI reduced their price objective on Teladoc Health from $8.00 to $7.00 and set an “in-line” rating for the company in a research note on Thursday. Jefferies Financial Group decreased their price target on shares of Teladoc Health from $10.00 to $8.00 and set a “hold” rating for the company in a research note on Monday, April 21st. Stifel Nicolaus dropped their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research note on Thursday. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a report on Thursday. Finally, Oppenheimer lowered their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th. Eleven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $9.81.

Teladoc Health Stock Up 1.1 %

TDOC opened at $7.07 on Monday. Teladoc Health has a one year low of $6.35 and a one year high of $15.21. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The stock has a market capitalization of $1.24 billion, a P/E ratio of -1.23 and a beta of 1.82. The business’s 50-day simple moving average is $8.02 and its 200-day simple moving average is $9.49.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%.

Institutional Trading of Teladoc Health

Several institutional investors have recently made changes to their positions in TDOC. Golden State Wealth Management LLC boosted its holdings in Teladoc Health by 102.6% in the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 1,690 shares during the last quarter. Versant Capital Management Inc lifted its stake in shares of Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 2,441 shares in the last quarter. Whipplewood Advisors LLC purchased a new stake in shares of Teladoc Health during the 4th quarter worth about $29,000. Lindbrook Capital LLC increased its position in Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after purchasing an additional 1,612 shares in the last quarter. Finally, Sterling Capital Management LLC raised its holdings in Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock valued at $42,000 after buying an additional 4,101 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This represents a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.58% of the stock is currently owned by corporate insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.